![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 3, 1645-1650, January 21, 2000
From the Laboratory for Molecular Biotechnology, Institute of
Animal Biology and Center for Biotechnology UNIL-EPFL, University of
Lausanne, 1015 Lausanne, Switzerland
Efficient initiation of SV40 DNA replication
requires transcription factors that bind auxiliary sequences flanking
the minimally required origin. To evaluate the possibility that
transcription factors may activate SV40 replication by acting on the
chromatin structure of the origin, we used an in vivo
replication system in which we targeted GAL4 fusion proteins to the
minimally required origin. We found that the proline-rich
transcriptional activation domain of nuclear factor I (NF-I), which has
been previously shown to interact with histone H3, specifically
activates replication. Evaluation of a series of deletion and point
mutants of NF-I indicates that the H3-binding domain and the
replication activity coincide perfectly. Assays with other
transcription factors, such as Sp1, confirmed the correlation between
the interaction with H3 and the activation of replication. These
findings imply that transcription factors such as NF-I can activate
SV40 replication via direct interaction with chromatin components,
thereby contributing to the relief of nucleosomal repression at the
SV40 origin.
Transcription factor binding sites are often found in sequences
adjacent to viral origins of replication. They stimulate replication by
modulating the efficiency of replication, but not the basic mechanism
of replication. Different mechanisms for the stimulation of replication
by transcription factors have been proposed. For instance, on the
adenovirus origin of replication, cellular transcription factors such
as NF-I,1 a member of the
CAAT box-binding transcription factor CTF/NF-I family of DNA-binding
proteins, activate replication by recruiting the viral DNA polymerase
to the origin (1-3). In other cases, replication depends on complex
arrays of transcription factor binding sites, such as in polyoma and
SV40. SV40 DNA replication initiates at a well-defined origin (SV40
ori) that is flanked by two auxiliary sequences. The binding motifs for
the Sp1 transcription factor contained in the auxiliary sequences are
required for efficient SV40 replication (4). SV40 is a relatively
simple and widely used model to study the activation of cellular DNA
replication because its initiation requires only one viral protein, the
large T-antigen; all the other proteins needed for initiation and
elongation are provided by the host cell (5). Furthermore, SV40
circular DNA is covered with nucleosomes, analogous to cellular
chromatin (6).
The mechanisms allowing SV40 replication activation by transcription
factors remain poorly understood. In vitro studies have suggested that transcription factors might recruit replication factors
such as Replication Factor A to the origin (7, 8). Alternatively, it
has been suggested that transcription factors prevent the chromatin
structure from interfering with the binding of initiation factors to
the replication origin, analogous to their probable role on promoters.
For instance, polyomavirus and SV40 auxiliary sequences are only
required in in vitro replication assays in the presence of
repressive chromatin structures (9). In infected cells, the SV40 ori is
free of nucleosomes in a fraction of the minichromosomes, which is
thought to represent the actively replicating fraction. It was
suggested that Sp1, which is necessary for efficient initiation of SV40
replication, is involved in these changes in chromatin structure (10).
Interestingly, both Sp1 and NF-I have been reported to bind histone H3,
suggesting an involvement of these transcription factors in chromatin
remodeling (11). NF-I has been implicated in the regulation of several steroid-sensitive promoters subjected to chromatin remodeling, and was
shown to mediate reconfiguration of reconstituted chromatin in
vitro (11-13). In addition, NF-I binding sites adjacent to the SV40 ori core have been shown to prevent chromatin-mediated repression of DNA replication in vitro (14). Thus, NF-I and other
transcription factors might function by perturbing the local
distribution of nucleosomes, thereby increasing the accessibility of
the origin to the replication machinery.
In this study we investigated whether transcription factors, namely
NF-I, can activate SV40 replication through their interaction with
chromatin components. We show that the activation domains of several
transcription factors previously shown to interact with H3 also mediate
SV40 replication activation. Both H3 interaction and replication were
found to be similarly reduced by a single amino acid substitution in
NF-I, thus strongly correlating the interaction with histone H3 with
the activation of replication. This study supports the role of
chromatin remodeling activities of transcription factors in the
activation of SV40 replication.
Plasmid Constructions--
The replication standard plasmid
pUCSV 40ori was constructed by inserting the
SalI-HindIII fragment of pSVori Mariacarmen (J. Sogo) into pUC19, cleaved with HindIII and
AflIII, after filling in the SalI and
AflIII site with the Klenow enzyme. For p5GAL4ori, the
replication reporter plasmid, the NcoI HindIII
fragment from pSVori Mariacarmen, was inserted into pCTF1 (15), cleaved
with NcoI and HindIII. This intermediate vector
was cut with BamHI and XbaI, and five GAL4
binding sites were inserted as a BglII-XhaI fragment from pG5BCAT (16). The sequences encoding the GAL4 fusion
proteins of NF-I (11) (GAL(399-499), GAL(438-499), and GAL(486-499))
were introduced as HindIII-EcoRV fragments from the respective pSGGAL fusion expression vectors into pRSV BXB (17), cut
with XbaI and HindIII, with the XbaI
site filled in with the Klenow enzyme. The coding sequences for
GAL(399-438), GAL(399-472), GAL(399-486), and GAL(438-472) were
transferred from their pSG424 backbone as
HindIII-XbaI fragments into pRSV BXB cleaved with
the same enzymes. The vectors with RSV promoter-driven expression of
the GAL4-NF-I fusions carrying a point mutation (GAL(399-499)YD491,
GAL(399-499)YD497, and GAL(399-499)YF497) were generated by cloning
the latter as HindIII and blunt-ended AflIII
fragments into pRSV BXB cleaved with HindIII and
Klenow-repaired BamHI.
For pRSV GAL(479-499)wt and the point mutation thereof,
GAL(479-499)YD497, the relevant fragments were removed from their parental pSG GAL4 fusion vector as HindIII and
Klenow-repaired BamHI fragments and cloned into the
HindIII and Klenow-repaired AflIII-cut vector
pRSV BXB. Coding sequences for the fusions GALSp1(132-243), GALOct2(99-161), and GALAp2(31-76) were removed from their pSG424 backbone (11, 18) by HindIII and XbaI and cloned
into HindIII-XbaI-cut pRSV BXB. pRSV
GALVP16(437-445) was generated by inserting the double-stranded
oligonucleotide coding for amino acids 437-445 of the VP16 activation
domain into pSG424, opened with EcoRI and XbaI.
This GAL fusion sequence was cloned into the
HindIII-XbaI vector fragment of pRSV BXB as a
HindIII-XbaI fragment.
The construction of pMLV-VP-H3(10-136) has been described previously
(11).
Cell Culture and Transfection--
For replication assays, COS7
cells were electroporated with a DNA mixture containing 1 µg of
pUCori replication standard plasmid, 10 µg of p5GAL4ori replication
reporter, and 10 µg of RSV expression vector. Sonicated salmon sperm
DNA (Sigma) was added to a total of 50 µg of transfected DNA. The
medium was supplemented with 50 µCi/ml [3H]thymidine.
Cells were harvested 36 h after transfection, and plasmid DNA was
extracted using the QIAQUICK plasmid extraction kit according to the
supplier's instructions (QIAGEN). DNA was eluted from the columns with
50 µl of H2O. Extracted plasmids were linearized by
BamHI and separated on a 0.6% agarose gel. Plasmid bands
were excised and subjected to scintillation counting in Hionic Fluor R
(Packard) to quantify the incorporated radiolabeled thymidine. The
value obtained for the reporter plasmid was normalized to that obtained
for the standard plasmid. For CAT assays, COS7 cells were
co-transfected with three plasmids: (a) an expression vector
for the indicated GAL4 fusions, (b) an expression vector for
VP16-transcriptional activation domain alone (VP) or an expression vector fused to amino acids 10-136 of histone H3 (VP-H3), and (c) the G5BCAT reporter construct. Cell extracts were
prepared with lysis buffer (Promega), and the assays were performed as described previously (11). All figures display the mean of at least
three experiments.
Gel Mobility Shift Assays--
For bandshift analysis of GAL
fusion proteins, transiently transfected COS7 cells were harvested
36 h after transfection, washed once in 1× phosphate-buffered
saline, and lysed in 100 µl of extraction buffer (20 mM
Tris, pH 7.5, 20% glycerol, 500 mM KCl, 1 mM
dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride) by
repeated freeze-thaw cycles, as described previously (19). Whole cell
lysates were normalized for total protein concentration. 4 µg of
total protein extract were incubated in 20 µl of extraction buffer
for 10 min at room temperature with a 32P end-labeled
double-stranded DNA probe containing the 17-base pair GAL4 binding site
(5'-GATCCGGGTCGGAGTACTGTCCTCCGACTGC-3'). Protein-DNA complexes were
separated from free probe on native 4% polyacrylamide gels as
described in Ref. 20 and revealed by phosphorimaging (Molecular Dynamics).
To evaluate the role of transcription factors in the activation of
SV40 replication, COS7 cells were transfected with a replication reporter plasmid containing five GAL4 binding sites adjacent to the
SV40 ori core, p5GALori, along with chimeric cDNA expression vectors for GAL fusion proteins. These encode the DNA binding and
dimerization domain of the yeast GAL4, either alone (amino acids
1-147; GAL DBD) or fused to the coding sequences of the transcriptional activation domains of CTF/NF-I (amino acids 399-499, GAL Pro) or Sp1 (amino acids 132-243, GAL Sp1) (Fig.
1A). A plasmid with the full
origin of replication, including both auxiliary sequences, was used as
an internal reference plasmid for transfection and replication (Fig.
1A, pUCori). SV40 DNA replication was assayed by
the addition of [3H]thymidine to the growth medium and by
the extraction of radiolabeled replicated DNA. To ascertain that the
recovered radiolabeled plasmids were true replication products, they
were digested with DpnI, which only cleaves methylated DNA
that has not been replicated. As an additional control, a digestion
with MboI was performed (Fig. 1B) because
MboI is dam methylation sensitive and cuts only non-methylated DNA. The recovered plasmids are cleaved by
MboI, but not by DpnI, and are therefore
replication products.
The presence of the five GAL4 binding sites had no influence per
se on the basal replication activity of the modified replication origins. No difference in replication activity was detected between the
two replication reporter plasmids p5GALori and pCori, a plasmid in
which the aux-2 sequence is deleted (data not shown). The proline-rich transcriptional activation domain of CTF/NF-I fused to GAL (Fig. 1B, GAL Pro) efficiently activated replication of p5GALori.
The expression of the DNA binding domain of GAL4 (GAL DBD) had a weak but significant activation effect on SV40 replication in the presence of GAL4 binding sites, consistent with previously published results (21, 22). In the absence of binding sites, GAL DBD and other GAL4
fusions had no effect on replication (data not shown).
H3-interacting Transcriptional Activation Domains Activate
Replication--
It has been proposed that Sp1 and NF-I bind histone
H3 and reorganize chromatin. Oct2, but not VP16, was also found to
interact with histone H3 in two-hybrid assays (11). Thus, the
activation domains of the latter transcription factors were tested for
their capacity to activate replication using the same experimental
approach as that used for NF-I. The activation by GAL NF-I was fixed as the reference level of replication and is used in all comparisons below. Whereas GAL Oct2 and GAL Sp1 stimulated replication, they did so
to a lesser extent than GAL NF-I. Activation by these transcription factors was not due to the mere presence of a transcriptional activation domain because expression of a GAL fusion containing the
VP16 activation domain or a portion thereof did not result in
detectable replication (Fig.
2A; data not shown).
Activation of replication by GAL Sp1 was expected because the aux-2
sequence contains Sp1 binding sites (23), and replacement of the aux-2 sequence with artificial Sp1 binding sites has been reported to activate SV40 replication in CV1 cells (24). Activation of replication by GAL Oct2 is also consistent with the previous finding that Oct
binding sites, which are found in the enhancer sequence of the SV40
promoter, can substitute for aux-2 when adjacent to the A/T-rich
element of the ori core (4, 25). NF-I and Oct2 may therefore substitute
for Sp1 in replication activation by using the same basic mechanism.
However, the activation domain of VP16 did not activate replication in
our assay in COS7 cells, indicating that the presence of a potent
transcriptional activation domain is not sufficient for replication
activation. This suggests that it is not transcriptional activity
per se that activates SV40 replication and that another
activity is required. Thus, there is a direct correlation between the
potential of the activation domains to activate SV40 replication and
the ability of the activation domains to interact with histone
H3.
To test for the interaction of these fusion proteins in COS7 cells,
two-hybrid transcription experiments were performed in parallel to the
replication assays. COS7 cells were transfected with the CAT reporter
construct, expression vectors for the indicated GAL fusion proteins,
and expression vectors for the VP16 activation domain, either alone
(VP) or fused to mouse histone H3.3 (VP-H3; Fig. 2B). An
interaction between a GAL fusion protein and H3 in VP-H3 recruits the
full-length VP16 transcriptional activation domain to the promoter,
thus leading to higher levels of transcription. When assayed for
transcriptional activity with VP16 alone, all GAL4 fusions activated
transcription, and the most potent of all was GAL VP16, as seen
previously (11). In the two-hybrid assay, the proline-rich activation
domain of NF-I interacts efficiently with histone H3 in COS7, as do the
activation domains of Sp1 and Oct2. However, no interaction between the
acidic transcriptional activation domain of VP16 and the VP16-H3 fusion
could be detected.
Control experiments were performed to rule out the possibility that
different activation levels may actually be due to different expression
levels of the activator proteins (Fig. 2C). Gel mobility shift assays demonstrated that all the fusion proteins were expressed at comparable levels and that the presence of H3-VP16 had no effect on
the expression levels of the GAL4 fusion proteins. We find a close
correlation between the H3 interaction and replication activation. The
three transcription factors that interacted with histone H3 also
significantly activated SV40 replication, whereas both VP16 and GAL DBD
did not significantly activate replication and did not interact with
histone H3 in the two-hybrid assay. Together, these data suggest that
the presence of a strong transcriptional activation domain, as seen in
GAL VP16, is not sufficient for replication activation and that the
other domains induce SV40 replication by interacting with H3.
Activation of Replication by Two NF-I Subdomains--
Six deletion
mutants of the proline-rich domain of NF-I were used to determine more
precisely which of its subdomains activate the SV40 origin of
replication. The C-terminal deletion mutants GAL(399-472) and
GAL(399-438) activated replication but did so less efficiently than
the full-length activation domain. This indicates that part of the
replication activity maps to the C terminus of the NF-I activation
domain. Further deletion of the N-terminal portions of the NF-I
transcriptional activation domain, as seen in GAL(438-472), resulted
in the loss of all activation potential. Thus, a second part of the
replication activation potential of the proline-rich domain resides in
the N-terminal portion. Indeed, N-terminal deletion mutants
GAL(438-499), GAL(472-499), and GAL(486-499) mediated reduced
replication as compared with the full-length domain (Fig.
3A). The loss of activation
potential of GAL(438-499) and GAL(399-472) compared with
GAL(399-438) and GAL(486-499) is most likely due to the presence of a
central inhibitory subdomain (amino acids 438-472). These results
indicate that both the C- and N-terminal portions of the NF-I
transcriptional activation domain are required for full activation of
the replication origin. In contrast, the central portion of the
proline-rich domain has no detectable effect on replication
activity.
The same deletion mutants were used to map the region of GAL(399-499)
that interacts with histone H3 in the two-hybrid assay. The assays for
H3 interaction and replication activation were performed in the same
transfections to allow a direct comparison of the results. The
C-terminal deletion mutants GAL(399-472) and GAL(399-438) show
strongly reduced transcriptional activation, 30- and 20-fold lower than
that of GAL(399-499) (Fig. 3B). However, their interaction
with H3 decreased but remained detectable, in keeping with their
transcriptional activity. Conversely, the N-terminal deletion mutant
GAL(438-499) showed both reduced transcriptional activity and H3
binding activity. As seen before, the expression of GAL4 fusions was
not affected by the coexpression of the histone fusion constructs (Fig.
3C). These data indicate that two NF-I domains interact with
H3 and mediate replication activation. One domain maps to the 13 C-terminal amino acids and is similar to the histone H3-interacting
domain first identified in mouse fibroblastic cells (11). Moreover,
GAL(472-499) and GAL(486-499) only modestly activate transcription on
their own, but they show high levels of activity when assayed for
interaction with the VP-H3 fusion protein and replication activation.
In addition, we identified another portion of the proline-rich domain
that also shows interaction with histone H3. This second histone
H3-interacting domain activated SV40 replication to approximately the
same extent as the C terminus, yet it did not significantly activate
transcription on its own. Deletion of both the C- and N-terminal
domains in mutant GAL(438-472) was required to inhibit both
interaction with histone H3 and replication activation.
Overall, the data indicate a dual role for C- and N-terminal
extremities of the NF-I transcriptional activation domain in histone H3
interaction and replication activation and imply that interaction with
the histone, rather than mere transcriptional activation, confers SV40
ori activation by NF-I.
A NF-I Point Mutant Inhibits both H3 Interaction and DNA
Replication--
The C-terminal portion of the transcriptional
activation domain is clearly one determinant of H3 interaction and
replication activation. To further evaluate the role of this domain, we
tested three GAL NF-I fusions bearing single point mutations at the C terminus.
GAL(399-499, Y491D) (tyrosine 491 changed to aspartate) and
GAL(399-499, Y497F) (tyrosine 497 changed to phenylalanine)
efficiently activated both replication and transcription, and
interaction with VP16-H3 did not significantly differ from wild type
GAL(399-499) (Fig. 4). In contrast, the
protein bearing a mutation of tyrosine to aspartate at position 497, GAL(399-499, Y497D), abolished the activation of p5GALori replication.
Transcriptional activation and histone interaction were also similarly
reduced with this mutation (Fig. 4B). Further deletion of
the N-terminal H3 interaction domain in the Y497D mutant abolished H3
interaction and replication activation, as expected (data not shown).
Overall, these results provide evidence that the proline-rich domain of
NF-I activates SV40 replication and further implicate the interaction
with histone H3 in SV40 replication activation.
Conclusions--
Previous studies have indicated that NF-I can
remodel chromatin in vitro, whereas Sp1 has been suggested
to maintain the SV40 origin nucleosome-free (14, 26). These findings,
together with the association of chromatin remodeling and
transcriptional activation at many promoters (27-29), may thus point
to chromatin remodeling as a common mechanism for the activation of
both transcription and replication. In both cases, chromatin structure
alteration by the action, direct or indirect, of transcription factors
would be an early step in activation. It is interesting to note that the H3-binding domain of NF-I is capable of restructuring the chromatin
of target promoters and concomitantly prevents heterochromatic silencing in yeast.2
Therefore, the binding of histone H3 by NF-I may be the key step by
which this transcription factor overcomes chromatin repression on both
promoters and replication origins.
We are grateful to J. Sogo for pSVori
Mariacarmen and to M. Zahn and L. Hunt for critical reading of the manuscript.
*
This work was supported by the Swiss National Science
Foundation, the Etat de Vaud, and the University of Lausanne
450th Anniversary Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
C. Boscheron, K. Müller, K. Carmine-Simmen, N. Mermod, and E. Gilson, manuscript in preparation.
The abbreviations used are:
NF-I, nuclear factor
I;
RSV, Rous sarcoma virus;
CAT, chloramphenicol acetyltransferase;
CTF, CAAT box-binding transcription factor.
The Histone-interacting Domain of Nuclear Factor I Activates
Simian Virus 40 DNA Replication in Vivo*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

View larger version (28K):
[in a new window]
Fig. 1.
Diagram of SV40 origin constructs and
in vivo assay for DNA replication. A,
anatomy of the SV40 origin of replication and reporter plasmid used in
this study. The SV40 origin region of pUCori, the construction used as
the reference plasmid in transfections, is shown. The nucleotide map
positions of SV40 minichromosomes and relevant restriction sites are
indicated at the bottom. The origin of DNA replication
consists of the origin core (nucleotides 31-5209) and auxiliary
sequences aux-1 (nucleotides 5208 to 5193) and aux-2 (nucleotides
30-72). aux-2 contains the GC-rich recognition sequence for
transcription factor Sp1 (5'-GGGCGG-3'). The AT-rich region comprises
the TATA box for early transcribed viral genes. Bidirectional DNA
replication starts from the DNA unwinding element (DUE).
T-antigen binds mainly to the ori core (ORE; origin
recognition element) and the aux-1 region. In plasmid p5GALori, five
binding sites for the yeast GAL4 protein were inserted. B,
replicated low molecular weight DNA was extracted from transfected COS7
cells as described under "Materials and Methods." Plasmids were
linearized with HindIII, with or without either
DpnI (to eliminate the non-replicated DNA) or
MboI. Plasmids were resolved by electrophoresis and detected
by autoradiography.

View larger version (26K):
[in a new window]
Fig. 2.
The transactivation domains of NF-I, Sp1, and
Oct2 activate replication at the SV40 origin and interact with histone
H3 in vivo. A, the proline-rich domain
of NF-I activates replication from the SV40 origin. COS7 cells were
electroporated with pUCori and p5GALori and with expression vectors for
GAL4 fusion proteins containing transcriptional activation domains of
different transcription factors. Replicated DNA was quantitated as
described under "Materials and Methods." Replication of the test
plasmid (p5GALori) was normalized to that of the internal standard,
pUCori. The replication measured in cells expressing GAL-NF-I was set
as 100%. B, the transcriptional activation domains of NF-I,
Sp1, and Oct2 interact with histone H3 in COS7 cells. COS7 cells were
transfected with the G5BCAT reporter construct, expression vectors for
the indicated GAL4 fusions, and a MLV expression vector for VP16
transcriptional activation domain, either alone (VP) or
fused to amino acids 10-136 of histone H3 (VP-H3). Lanes
with VP show the basal transcriptional activity of each of the
transcription factors, whereas lanes with VP-H3 express the increase in
transcriptional activity resulting from the interaction between H3 and
the indicated transcription factor. CAT activities were determined as
described previously (11). The CAT value obtained with cells expressing
GAL-NF-I was set as 100%. The regions of the transcriptional
activation domains tested are indicated. C, GAL fusion
proteins are well expressed in COS7 cells, and expression of H3-VP16
does not significantly affect the GAL fusion expression level. COS7
cells were transiently transfected with vectors expressing the
indicated GAL4 fusion proteins, together with expression vectors for
H3VP16 or VP16. Cell lysates were analyzed for GAL4 DNA binding
activity using a gel mobility shift assay; equal amounts of total
protein were used in each lane. mock, mobility shift assays
performed with lysates from cells transfected with empty expression
vectors.

View larger version (26K):
[in a new window]
Fig. 3.
Two subregions of the NF-I proline-rich
domain mediate replication and interaction with histone H3 in COS7
cells. A, COS7 cells transfected with the indicated
deletion mutants of the CTF/NF-I transcriptional activation domain
fused to the GAL4 DNA binding domain, and DNA replication was assayed
as described in the Fig. 2 legend. Replication activity was normalized
to that of the internal standard plasmid, pUCori, and the value
obtained for cells expressing the Gal-NF-I and VP16-histone H3 fusions
was set as 100%. B, the C-terminal part of the proline-rich
domain of CTF/NF-I mediates interaction with histone H3 in COS7 cells.
COS7 cells were transfected as described in the Fig. 2 legend with the
deletion mutants of the transcriptional activation domain indicated.
CAT activity was assessed 36 h after transfection. C,
bandshift analysis of GAL4 fusion of NF-I deletion mutants. The
experiment was performed as described in the legend to Fig.
2C.

View larger version (27K):
[in a new window]
Fig. 4.
Activation of replication is abolished by a
point mutant that markedly affects transcription. A,
COS7 cells were transfected with the replication reporter plasmid,
p5GALori, the internal standard plasmid, pUCori, and expression vectors
for GAL-NF-I fusion proteins containing either the wild type NF-I
proline-rich domain or the far C-terminal portion of NF-I
transcriptional activation domain bearing point mutations. The tyrosine
at position 491 was either left unchanged (GAL 399-499
W.T.) or mutated to aspartic acid (GAL 399-499 Y491D).
The tyrosine at position 497 was changed to either aspartic acid
(GAL 399-499 Y497D) or phenylalanine (GAL 399-499
Y497F). Radiolabeling, cell harvesting, and quantification of the
replicated plasmids were performed as described in the Fig. 2 legend.
B, COS7 cells were transfected with G5BCAT, CMV
gal, the
vector coding for either VP-H3 or VP alone, and expression vectors for
GAL-NF-I bearing point mutations in the C-terminal portion of the
transcriptional activation domain, as specified in the figure. CAT
activity was determined 36 h after transfection and is expressed
relative to the normalized CAT activity obtained for cells expressing
wild type GAL(399-499), which was set as 100. C, bandshift
analysis of GAL4 fusions of NF-I point mutants. The experiment was
performed as described in the legend to Fig. 2C.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Laboratory of
Molecular Biotechnology, Center for Biotechnology UNIL-EPFL, Department of Chemistry, Swiss Federal Institute of Technology-Lausanne, 1015 Lausanne, Switzerland. E-mail: nicolas.mermod@iba.unil.ch.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
1.
Nagata, K.,
Guggenheimer, R. A.,
Enomoto, T.,
Lichy, J.,
and Hurwitz, J.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
6438-6442 2.
Mul, A. M.,
and van der Vliet, P. C.
(1992)
EMBO J.
11,
751-760[Medline]
[Order article via Infotrieve]
3.
Armentero, M. T.,
Horwitz, M. S.,
and Mermod, N.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11537-11541 4.
Guo, Z.,
Gutierrez, C.,
Heine, U.,
Sogo, J. M.,
and DePamphilis, M. L.
(1989)
Mol. Cell. Biol.
9,
3593-3602 5.
Kelly, T. J.
(1988)
J. Biol. Chem.
263,
17889-17892 6.
Cremisi, C.,
Pignatti, F.,
Croissant, O.,
and Yaniv, M.
(1976)
J. Virol.
17,
204-211 7.
Li, R.,
and Botchan, M. R.
(1993)
Cell
73,
1207-1221[CrossRef][Medline]
[Order article via Infotrieve]
8.
He, Z.,
Brinton, B. T.,
Greenblatt, J.,
Hassell, J. A.,
and Ingles, C. J.
(1993)
Cell
73,
1223-1232[CrossRef][Medline]
[Order article via Infotrieve]
9.
Majumder, S.,
Miranda, M.,
and DePamphilis, M.
(1993)
EMBO J.
12,
1131-1140[Medline]
[Order article via Infotrieve]
10.
Gruss, C.,
and Sogo, J. M.
(1992)
Bioessays
14,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
11.
Alevizopoulos, A.,
Dusserre, Y.,
Tsai-Plugfelder, M.,
von der Weid, T.,
Wahli, W.,
and Mermod, N.
(1995)
Genes Dev.
9,
3051-3066 12.
Archer, T.,
Cordingley, M.,
Wolford, R.,
and Hager, G.
(1991)
Mol. Cell. Biol.
11,
688-689 13.
Schild, C.,
Claret, F. X.,
Wahli, W.,
and Wolffe, A. P.
(1993)
EMBO J.
12,
423-433[Medline]
[Order article via Infotrieve]
14.
Cheng, L.,
and Kelly, T. J.
(1989)
Cell
59,
541-551[CrossRef][Medline]
[Order article via Infotrieve]
15.
Mermod, N.,
O'Neill, E. A.,
Kelly, T. J.,
and Tjian, R.
(1989)
Cell
58,
741-753[CrossRef][Medline]
[Order article via Infotrieve]
16.
Lillie, J. W.,
and Green, M. R.
(1989)
Nature
338,
39-44[CrossRef][Medline]
[Order article via Infotrieve]
17.
Bruder, J. T.,
Heidecker, G.,
and Rapp, U. R.
(1992)
Genes Dev.
6,
545-556 18.
Seipel, K.,
Georgiev, O.,
and Schaffner, W.
(1992)
EMBO J.
11,
4961-4968[Medline]
[Order article via Infotrieve]
19.
Martinez, E.,
Dusserre, Y.,
Wahli, W.,
and Mermod, N.
(1991)
Mol. Cell. Biol.
11,
2937-2945 20.
Carey, M.,
Kakidani, H.,
Leatherwood, J.,
Mostashari, F.,
and Ptashne, M.
(1989)
J. Mol. Biol.
209,
423-432[CrossRef][Medline]
[Order article via Infotrieve]
21.
Cheng, L.,
Workman, J. L.,
Kingston, R. E.,
and Kelly, T. J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
589-593 22.
Bennett-Cook, E. R.,
and Hassell, J. A.
(1991)
EMBO J.
10,
959-969[Medline]
[Order article via Infotrieve]
23.
Kelman, Z.,
and O'Donnell, M.
(1994)
Curr. Opin. Genet. Dev.
4,
185-195[CrossRef][Medline]
[Order article via Infotrieve]
24.
Lednicky, J.,
and Folk, W. R.
(1992)
J. Virol.
66,
6379-6390 25.
Lee-Chen, G. J.,
and Woodworth-Gutai, M.
(1986)
Mol. Cell. Biol.
6,
3086-3093 26.
Sogo, J. M.,
Stahl, H.,
Koller, T.,
and Knippers, R.
(1986)
J. Mol. Biol.
189,
189-204[CrossRef][Medline]
[Order article via Infotrieve]
27.
Beato, M.,
and Eisfeld, K.
(1997)
Nucleic Acids Res.
25,
3559-3563 28.
Wolffe, A. P.
(1994)
Trends Biochem. Sci.
19,
240-244[CrossRef][Medline]
[Order article via Infotrieve]
29.
Kadonaga, J. D.
(1998)
Cell
92,
307-313[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. M. Johansson, M. Kannius-Janson, A. Gritli-Linde, G. Bjursell, and J. Nilsson Nuclear Factor 1-C2 Is Regulated by Prolactin and Shows a Distinct Expression Pattern in the Mouse Mammary Epithelial Cells during Development Mol. Endocrinol., April 1, 2005; 19(4): 992 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ferrari, K. C. Simmen, Y. Dusserre, K. Muller, G. Fourel, E. Gilson, and N. Mermod Chromatin Domain Boundaries Delimited by a Histone-binding Protein in Yeast J. Biol. Chem., December 31, 2004; 279(53): 55520 - 55530. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lefevre, S. Melnik, N. Wilson, A. D. Riggs, and C. Bonifer Developmentally Regulated Recruitment of Transcription Factors and Chromatin Modification Activities to Chicken Lysozyme cis-Regulatory Elements In Vivo Mol. Cell. Biol., June 15, 2003; 23(12): 4386 - 4400. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Hebbar and T. K. Archer Nuclear Factor 1 Is Required for Both Hormone-Dependent Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter Mol. Cell. Biol., February 1, 2003; 23(3): 887 - 898. [Abstract] [Full Text] |
||||
![]() |
A.-Y. Xie, V. P. Bermudez, and W. R. Folk Stimulation of DNA Replication from the Polyomavirus Origin by PCAF and GCN5 Acetyltransferases: Acetylation of Large T Antigen Mol. Cell. Biol., November 15, 2002; 22(22): 7907 - 7918. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liao, F. Y. Wu, and S. D. Hayward Interaction with the Epstein-Barr Virus Helicase Targets Zta to DNA Replication Compartments J. Virol., September 15, 2001; 75(18): 8792 - 8802. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Turner and M. E. Woodworth DNA Replication Efficiency Depends on Transcription Factor-Binding Sites J. Virol., June 15, 2001; 75(12): 5638 - 5645. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |